Hospira to raise awareness about biogenerics

One of the many big health issues on the table this year is generic biologics.

Hospira, a pharmaceutical company which develops generic injectable drugs,...

One of the many big health issues on the table this year is generic biologics.

Hospira, a pharmaceutical company which develops generic injectable drugs, launched an awareness effort May 5 about generic biologic drugs, reports The Wall Street Journal.

The company added a running clock to its Web site, tallying the billions of dollars Americans spend each year on biologic drugs.

The site also includes educational and cost-saving information about biogenerics and a link to send a message to leaders in Congress urging them to support a bill that would allow the Food and Drug Administration (FDA) to approve generic versions of biologic drugs.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.